Companies: 10,795·Total market cap: $144.5T

COMPASS Pathways plc

COMPASS Pathways plc

CMPSNASDAQHealthcare● Active

$12.11

$-0.94(-7.20%)

Market Cap$1.2B

P/E Ratio—

52W High$14.76

52W Low$2.25

Avg Volume4.0M

Open$12.87

Beta2.51

股票排行：Medical - Care Facilities·Healthcare·查看全部市值排行 →

COMPASS Pathways plc（CMPS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CMPS · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.15Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding93.5MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

探索 COMPASS Pathways plc 数据

分析师预测$18 · Buy

股息不分红

盈利EPS $-3.08-33.91%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$287.9M▼ 85.57% YoY

202320242025

FY 2025EPS$-3.08▼ 33.91% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$178.9MEPS: $-2.15View income statement →

分析师评级与目标价

Buy13 位分析师

Strong Buy

0

Buy

12

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$15.00Low

$12.11Current

$18.13Avg Target上涨空间 49.71%

$22.00High

合计: 13 · 买入占比: 92.3%

根据过去 3 个月内 13 位华尔街分析师，CMPS 共识评级为 Buy，12 个月平均目标价 $18.13 （较现价 $12.11 上涨空间 49.71%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

COMPASS Pathways plc

$12.11-7.20%$1.2B #2

Avanos Medical, Inc.

$25.05+0.20%$1.2B #3

Community Health Systems, Inc.

$2.74-1.79%$386.1M #4

$13.80+0.07%$706.9M #5

4D Molecular Therapeutics, Inc.

$8.64-13.69%$451.7M #6

Gossamer Bio, Inc.

$0.18-1.57%$41.1M

股票表现

1D-7.20%

1W-9.36%

1M+22.20%

3M+84.04%

YTD+75.51%

1Y+159.31%

5Y-66.56%

关于 COMPASS Pathways plc

CEOKabir Kumar Nath

IPO DateSep 18, 2020

Employees166

CountryGB

Websitecompasspathways.com

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical tri…

Medical - Care Facilities HealthcareNASDAQADRGB

关于股票概览与关键数据

COMPASS Pathways plc（CMPS）是 Medical - Care Facilities 行业的 Healthcare 类公司，于 Sep 18, 2020 在 NASDAQ 上市。截至最近交易日，CMPS 股价为 $12.11，市值约为 $1.2B。过去12个月累计回报 +159.31%，年初至今回报 +75.51%。

根据 13 位华尔街分析师，COMPASS Pathways plc 股票共识评级为Buy，12个月平均目标价为 $18.13。2025 财年 COMPASS Pathways plc 营收 —，净利润 -$287.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，COMPASS Pathways plc（CMPS）股价为 $12.11，在 NASDAQ 上市，52周区间为 $2.25 – $14.76。

CMPS 最新股价CMPS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议